A Dutch company specialising in drug delivery has raised €10 million in a Series C financing round to advance its early-stage portfolio of treatments for brain tumours and neuroinflammatory conditions. The company is called to-BBB technologies BV. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
